FDA Chief Cracks Down on Illegal Copycat Drugs

The US FDA, under the leadership of Chief Makary, has announced plans to swiftly address the issue of illegal copycat drugs on the market. These unauthorized drugs are marketed as similar to FDA-approved products but lack official approval.

Makary issued a strong warning, stating that the FDA is unable to verify the quality, safety, or effectiveness of these non-approved drugs. This poses significant health risks to consumers who might be misled by such claims.

This action reflects the FDA's commitment to protecting public health by ensuring that only safe and effective pharmaceuticals reach the market. Consumers are urged to remain vigilant and skeptical of products claiming FDA equivalence without proper approval.